IgA : an immune glycoprotein

IgA is a glycoprotein containing multiple N-linked carbohydrates as well as O-linked glycans in the case of IgA1. Because of the critical role it plays in providing protection at mucosal surfaces, IgA is an ideal candidate for use as a therapeutic or prophylactic agent. The presence or absence of ca...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 116(2005), 1 vom: 30. Juli, Seite 3-10
1. Verfasser: Yoo, Esther M (VerfasserIn)
Weitere Verfasser: Morrison, Sherie L
Format: Aufsatz
Sprache:English
Veröffentlicht: 2005
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Review Glycoproteins IgA receptor Immunoglobulin A Receptors, Fc Peptide Hydrolases EC 3.4.-
LEADER 01000naa a22002652 4500
001 NLM155681281
003 DE-627
005 20231223072635.0
007 tu
008 231223s2005 xx ||||| 00| ||eng c
028 5 2 |a pubmed24n0519.xml 
035 |a (DE-627)NLM155681281 
035 |a (NLM)15925826 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Yoo, Esther M  |e verfasserin  |4 aut 
245 1 0 |a IgA  |b an immune glycoprotein 
264 1 |c 2005 
336 |a Text  |b txt  |2 rdacontent 
337 |a ohne Hilfsmittel zu benutzen  |b n  |2 rdamedia 
338 |a Band  |b nc  |2 rdacarrier 
500 |a Date Completed 09.08.2005 
500 |a Date Revised 16.11.2005 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a IgA is a glycoprotein containing multiple N-linked carbohydrates as well as O-linked glycans in the case of IgA1. Because of the critical role it plays in providing protection at mucosal surfaces, IgA is an ideal candidate for use as a therapeutic or prophylactic agent. The presence or absence of carbohydrates, as well as their structure, has been found to influence effector functions and binding to specific IgA receptors. In addition, changes in IgA glycosylation are associated with immune pathology. A thorough understanding of the contributions of the glycans to IgA immune protection will aid in the design of clinically suitable antibodies 
650 4 |a Journal Article 
650 4 |a Review 
650 7 |a Glycoproteins  |2 NLM 
650 7 |a IgA receptor  |2 NLM 
650 7 |a Immunoglobulin A  |2 NLM 
650 7 |a Receptors, Fc  |2 NLM 
650 7 |a Peptide Hydrolases  |2 NLM 
650 7 |a EC 3.4.-  |2 NLM 
700 1 |a Morrison, Sherie L  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Clinical immunology (Orlando, Fla.)  |d 1999  |g 116(2005), 1 vom: 30. Juli, Seite 3-10  |w (DE-627)NLM098196855  |x 1521-7035  |7 nnns 
773 1 8 |g volume:116  |g year:2005  |g number:1  |g day:30  |g month:07  |g pages:3-10 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_24 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 116  |j 2005  |e 1  |b 30  |c 07  |h 3-10